Genç Gençer, Atalar Merve Sapmaz
University of Health Sciences, Şişli Hamidiye Etfal Training and Research Hospital, Department of Neurology, İstanbul, Turkey.
University of Health Sciences, Hamidiye Faculty of Health Sciences, Department of Speech and Language Therapy, İstanbul, Turkey.
Noro Psikiyatr Ars. 2022 Dec 5;60(1):49-54. doi: 10.29399/npa.28053. eCollection 2023.
To evaluate the validity and reliability of the Turkish version of the Sialorrhea Clinical Scale for Parkinson's disease (SCS-PD) for use in clinical settings.
The original English version of SCS-PD has been adapted to Turkish (SCS-TR) in accordance with international guidelines. Forty-one patients with Parkinson's Disease (PD) and 31 healthy people were included in our study. SCS-TR, Movement Disorders Society United Parkinson's Disease Rating Scale (MDS-UPDRS) Part II (functional subscale 2.2 Saliva and drooling), Drooling Frequency and Severity Scale (DFSS) and The Non-Motor Symptoms Questionnaire (NMSQ) (1st question evaluating saliva) were applied to both groups. The adapted scale was re-tested in PD patients 2 weeks later.
A statistically significant relationship was determined between the SCS-TR scale score and all similar scale scores (NMSQ, MDS-UPDRS, DFSS) (p<0.001). The correlation between SCS-TR and similar scales scores was high, linear and positive (84.8% for MDS-UPDRS, 72.3% for DFSS and 70.1% for NMSQ). The Cronbach's alpha coefficient for the evaluation of the reliability of the sialorrhea clinical scale questionnaire was found to be 0.881 which indicates a very good internal consistency. Spearman's correlation test evaluating the relationship between the scores of the preliminary test and re-test of SCS-TR showed a high level, linear and positive relationship.
SCS-TR is consistent with the original version of SCS-PD. As its validity and reliability in Turkey have been shown by our study, it can be used for the evaluation of sialorrhea in Turkish PD patients.
评估帕金森病流涎临床量表土耳其语版(SCS-TR)在临床环境中使用的有效性和可靠性。
SCS-PD的原始英文版已根据国际指南改编为土耳其语版(SCS-TR)。我们的研究纳入了41例帕金森病(PD)患者和31名健康人。两组均应用SCS-TR、运动障碍协会统一帕金森病评定量表(MDS-UPDRS)第二部分(功能亚量表2.2唾液和流涎)、流涎频率和严重程度量表(DFSS)以及非运动症状问卷(NMSQ)(评估唾液的第一个问题)。2周后在PD患者中对改编后的量表进行重新测试。
确定SCS-TR量表评分与所有类似量表评分(NMSQ、MDS-UPDRS、DFSS)之间存在统计学显著关系(p<0.001)。SCS-TR与类似量表评分之间的相关性高、呈线性且为正(MDS-UPDRS为84.8%,DFSS为72.3%,NMSQ为70.1%)。发现用于评估流涎临床量表问卷可靠性的克朗巴赫α系数为0.881,这表明内部一致性非常好。评估SCS-TR初步测试和重新测试评分之间关系的斯皮尔曼相关性检验显示出高水平、线性且为正的关系。
SCS-TR与SCS-PD的原始版本一致。由于我们的研究已证明其在土耳其的有效性和可靠性,它可用于评估土耳其PD患者的流涎情况。